Evidence map›Paper›PMID 25999234›Full record

ReviewExperimental eye research2015

Tools and resources for analyzing gene expression changes in glaucomatous neurodegeneration.

Robert W Nickells, Heather R Pelzel

Abstract readReview
In one paragraph

Review in Experimental eye research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. BCLXCell death & disease · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robert W NickellsDepartment of Ophthalmology and Visual Sciences, University of Wisconsin - Madison, Madison, WI, USA; McPherson Eye Research Institute, University of Wisconsin - Madison, Madison, WI, USA. Electronic address: nickells@wisc.edu.
Heather R PelzelDepartment of Biological Sciences, University of Wisconsin - Whitewater, Whitewater, WI, USA.

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
The molecular mechanism of retinal ganglion cell deathR01EY012223 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI NICKELLS, ROBERT W · 2005 to 2017
$6.3M
Characterization of RGC death susceptibility allelesR01EY018869 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI NICKELLS, ROBERT W · 2009 to 2013
$1.5M
NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY012223NEI NIH HHS R01EY012223NEI NIH HHS R01 EY018869
6 · The paper itself

Abstract

Evaluating gene expression changes presents one of the most powerful interrogative approaches to study the molecular, biochemical, and cellular pathways associated with glaucomatous disease pathology. Technologies to study gene expression profiles in glaucoma are wide ranging. Qualitative techniques provide the power of localizing expression changes to individual cells, but are not robust to evaluate differences in expression changes. Alternatively, quantitative changes provide a high level of stringency to quantify changes in gene expression. Additionally, advances in high throughput analysis and bioinformatics have dramatically improved the number of individual genes that can be evaluated in a single experiment, while dramatically reducing amounts of input tissue/starting material. Together, gene expression profiling and proteomics have yielded new insights on the roles of neuroinflammation, the complement cascade, and metabolic shutdown as important players in the pathology of the optic nerve head and retina in this disease.

Indexed as

Gene Expression RegulationGlaucomaAnimalsDisease Models, AnimalEye ProteinsGene Expression ProfilingOptic DiskRetinal Ganglion CellsRNAEye ProteinsRNAGene expression profilingGlaucomaMicroarrayOptic nerve headProteomicsRetinaRetinal ganglion cellsRT-qPCRTranscriptome

Identifiers

PMID25999234
PMCPMC4628862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.